Structural characterization of inclusion complex of arbutin and hydroxypropyl-β-cyclodextrin by Li, Yun et al.
Li et al 
Trop J Pharm Res, October 2016; 15(10): 2227  
 
Tropical Journal of Pharmaceutical Research October 2016; 15 (10): 2227-2233 
ISSN: 1596-5996 (print); 1596-9827 (electronic) 
© Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria.  
All rights reserved. 
 
Available online at http://www.tjpr.org 
http://dx.doi.org/10.4314/tjpr.v15i10.22 
Original Research Article 
 
 
Structural characterization of inclusion complex of arbutin 
and hydroxypropyl-β-cyclodextrin 
 
Yun Li1, Fang Li1,2, Hongyan Cai1, Xuan Chen1, Wei Sun1, Wangyang Shen1,2* 
1School of Food Science and Technology, Wuhan Polytechnic University, 2Hubei Collaborative Innovation Center for 
Processing of Agricultural Products, Wuhan 430023, China 
 
*For correspondence: Email: whwangyangshen@126.com; Tel: +86-27-83924790; Fax: +86-27-83924790 
 
Received: 24 May 2016        Revised accepted: 14 September 2016 
 
Abstract 
Purpose: To improve the solubility and stability of arbutin and to expand its application by preparing its 
inclusion complex with hydroxypropyl-β- cyclodextrin (HP-β-CD). 
Methods: An inclusion complex made of arbutin and hydroxypropyl-β-cyclodextrin (HP-β-CD) was 
prepared by freeze-drying method. Various analytical techniques, including ultraviolet-visible 
spectroscopy (UV), Fourier transform infrared spectroscopy (FT-IR), scanning electron microscopy 
(SEM), x-ray diffractometry (XRD) and thermo-gravimetric/differential scanning calorimetry (TG/DSC), 
were used to characterize the inclusion complex.  
Results: UV spectra indicated that no new unsaturated bond was formed in the inclusion complex. 
Infrared analysis showed that the smaller peaks in the proximity of 1450 - 1600 cm-1 were characteristic 
of the aromatic nucleus, indicating that the phenyl ring of arbutin was involved in the formation of the 
inclusion complex. Scanning electron micrographs of the inclusion complex showed that the original 
morphology of both components disappeared, and some tiny aggregates of amorphous areas of 
irregular size were present, revealing that the arbutin was dispersed in HP-β-CD. The powder XRD 
pattern of the inclusion complex was more similar to that of amorphous HP-β-CD and did not exhibit the 
characteristic peaks of arbutin which suggest that arbutin in HP-β-CD matrix was molecularly dispersed, 
and existed in an amorphous state. The TG curve of the inclusion complex was a one-step process, 
partly proving the formation of the complex. Complex formation with HP-β-CD remarkably improved the 
physical and chemical stabilities of arbutin.   
Conclusion: Inclusion complex of arbutin with HP-β-CD improves the heat stability of arbutin 
remarkably. This has a potential for expanding the application of arbutin to pharmaceuticals and food.  
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is an important phenolic compound found in 
many plants and fruits [1]. It has potent 
antifungal, antiviral and anticancer activities [2-4]. 
Arbutin was initially identified as an antibiotic 
substance in fire blight resistance [5], and later 
as a specific marker for evaluation of pear 
product authenticity [6]. It has also attracted 
attention for its antitussive and antibacterial 
effects.  Studies have shown that arbutin has 
antioxidant properties [7-9] and is rich in phenolic 
compounds [9,10].  Arbutin inhibits biosynthesis 
of the human pigment melanin, which is the basis 
of its application in skin-lightening cosmetics 
[11,12]. Arbutin is also used to treat infections of 
the urogenital tract [13].  
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However, the poor aqueous solubility and poor 
stability of arbutin in water has restricted its 
application.  Water solubility of natural 
compounds is generally improved by 
glycosylation using enzymatic or chemical 
methods. Glycosylation is an important process 
used to structurally modify biologically active 
phenolic compounds, so as to render them more 
soluble in aqueous systems and increase their 
stability to light and oxidation. Attachment of a 
sugar moiety to a molecule increases its 
hydrophilicity and improves its physicochemical 
and pharmacokinetic properties [14]. However, a 
water-soluble polymer containing glucose 
residues may cause biological responses when it 
is metabolized. The glycosyl structures are 
appropriately modified [15]. Animal studies have 
shown that arbutin metabolites have hepatotoxic, 
nephrotoxic, mutagenic and carcinogenic 
potential [16,17]. Thus, glycosylation may create 
a group of new compounds with unknown safety, 
making it necessary to ascertain their safety 
before their application in food or medicines [18]. 
  
Cyclodextrins (CDs) are non-toxic macrocyclic 
oligosaccharides consisting of (α-1, 4)-linked α-L-
glucopyranose units. With hydrophilic outer 
surfaces and hollow hydrophobic interiors, CDs 
are very attractive ingredients for making artificial 
enzymes and other biomimetic materials. They 
are readily available. They can bind hydrophobic 
substrates into their cavities in aqueous 
solutions, and they have two rows of hydroxyl 
groups that can either react with substrates 
themselves or be widely used to attach other 
catalytic functional groups. Consequently CDs 
are widely used in the food industry as food 
additives, for stabilization of flavors, for 
elimination of undesired tastes or other 
undesired compounds such as cholesterol and 
for prevention of microbiological contaminations 
and browning reactions [19,20]. The most 
common CDs used as formulation vehicles are 
α-, β- and γ-CDs containing six, seven and eight 
glucopyranose units, respectively. 
 
Hydroxylpropyl-β-cyclodextrin (HP-β-CD), a 
hydroxyalkyl derivative, is an alternative to α-, β- 
and γ-CDs. It has improved water solubility and 
may be more toxicologically benign [21,22]. It 
has been confirmed that HP-β-CD is well 
tolerated in humans, the main adverse event 
being diarrhoea [23].  
 
To the best of our knowledge, there are no 
reports on preparation of   an inclusion complex 
of arbutin and HP-β-CD. In this study, we 
prepared an inclusion complex of arbutin with 
HP-β-CD for the first time, studied its  
physicochemical properties and characterized it 
by ultraviolet-visible spectroscopy (UV), Fourier 
transform infrared spectroscopy (FT-IR), 
scanning electron microscopy (SEM), X-ray 
diffractometry (XRD) and 
thermogravimetric/differential scanning 




Materials and chemicals 
 
Arbutin (> 99 %) was obtained from Shanxi 
Huike Botanical Development Co., Ltd., (Xi’an, 
China). Hydroxypropyl-β-cyclodextrin (MW 1460) 
was obtained from Sigma Chemical Co. (USA). 
All other chemicals and solvents were of 
analytical grade. 
 
Preparation of the inclusion complex of 
arbutin and HP-β-CD 
 
The complex was prepared by mixing arbutin and 
HP-β-CD, 1:1 molar ratio, using freeze-drying 
method. Arbutin (0.272 g) and HP-β-CD (1.460 
g) were dispersed in 50 mL of distilled water; the 
mixture was kept stirred for 72 h at 40 °C, and 
then filtered. The filtrate was freeze-dried, and to 
yield the powdery inclusion complex, which was 
collected for the physicochemical analysis. 
 
Preparation of physical mixture of arbutin 
and HP-β-CD 
 
Arbutin and HP-β-CD were separately pulverized 
in ceramic mortars. Thereafter, arbutin and HP-
β-CD were mixed at a molar ratio of 1:1 in a 
spatula to obtain l a homogeneous mixture. 
 
UV-visible spectroscopy (UV) 
 
UV spectra were recorded for arbutin, HP-β-CD, 
their physical mixture and inclusion complex 
using a TU-1810PC spectrophotometer (Beijing 
Purkinje General Instrument Co., Ltd., Beijing, 
China). Each sample was dissolved in distilled 
water at room temperature. The aqueous 
solutions were scanned in the wavelength range 
of 200 to 400 nm to obtain the UV spectra. 
 
Fourier transform infrared spectroscopy (FT-
IR) 
 
IR spectra of arbutin, HP-β-CD, their physical 
mixture and inclusion complex were obtained  
between 4000 and 400 cm-1 (Mid infrared region) 
on a TENSOR 27 infrared spectrophotometer 
(Bruker, Germany) with 256 scans at a resolution 
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of 4 cm-1. Each sample was ground with 
spectroscopic grade potassium bromide (KBr) 
powder and then pressed into 1 mm pellets (2 
mg of sample per 200 mg dry KBr). A blank KBr 
disk was used as background/control. 
 
Scanning electron microscopy (SEM) 
 
Surface morphologies of arbutin, HP-β-CD, their 
physical mixture and inclusion complex were 
investigated using a Quanta 200 environmental 
scanning electron microscope (FEI, USA). Prior 
to examination, the samples were prepared by 
mounting about 0.5 mg of powder onto a 5 mm × 
5 mm silicon wafer affixed via graphite tape to an 
aluminum stub. Then the samples were 
examined at the accelerating potential of 15 kV 
under low vacuum.  
 
X-ray diffractometry (XRD) 
 
Monochromatic Cu Ka radiation (wavelength = 
1.54056 A˚) was produced by a D8 X-ray 
diffractometer (Bruker, Germany). Each sample 
powder was packed tightly in a rectangular 
aluminum cell. The samples were exposed to the 
x-ray beam from an x-ray generator. The 
scanning regions of the diffraction angle, 2θ, 
were 5 – 80˚. Duplicate measurements were 
made at ambient temperature. Radiation was 





Q600 TG/DSC system (TA, USA) was adjusted 
to operate  in dynamic atmosphere of nitrogen 
(99.999 %) at 100 mL/min and heating rate of 20 
°C/min from 20 to 500 °C, with a sample mass of 
about 5 mg. 
RESULTS 
 
The absorption spectra of arbutin, HP-β-CD, their 
physical mixture and inclusion complex are 
presented in Figure 1. Due to the absence of 
double bond, there is no absorption peak for HP-
β-CD. However, two remarkable absorption 
peaks were found at wavelengths of 221 nm and 
283 nm, which were confirmed as the 
characteristic absorption peaks of arbutin. 
 
The infrared spectra of arbutin, HP-β-CD, their 
physical mixture and inclusion complex are 
shown in Figure 2. For HP-β-CD in this IR 
spectrum, several prominent absorption bands 
were found at 3403 cm-1 (for O-H stretching 
vibrations), 2930 cm-1 (for C-H stretching 
vibrations) and 1157, 1084 and 1033 cm-1 (for C-
H, C-O stretching vibration). The FT-IR spectrum 
of arbutin consisted of the prominent absorption 
bands of the hydroxyl group (3373cm-1) and the 
aromatic nucleus (1512, 1461, 1411 cm-1). It is 
interesting that an additive effect of arbutin and 
HP-β-CD was displayed in both the IR spectra of 
the physical mixture and the inclusion complex. 
Although all the characteristic absorption peaks 
of arbutin and HP-β-CD could still be found, the 
spectrum of the complex was mainly affected by 
the HP-β-CD, in disappearance of some 
characteristic absorption peaks of arbutin in the 
wavelength bands between 400 and 1500 cm-1. 
The smaller peaks in the proximity of 1450 - 
1600 cm-1 are characteristic of the aromatic 
nucleus, indicating that the phenyl ring of arbutin 





Figure 1: UV spectra of HP-β-CD (a), arbutin (b), their physical mixture (c); and inclusion complex (d) 
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Figure 2: IR spectra of HP-β-CD (a), arbutin (b), their physical mixture (c), and inclusion complex (d) 
 
The surface morphology of the powders derived 
from arbutin, HP-β-CD, their physical mixture 
and complex was assessed by SEM. As 
illustrated in Plate 1, HP-β-CD was observed as 
amorphous spheres (Plate 1a), whereas the 
arbutin existed in the form of needle-like crystals 
(Plate 1b). Both characteristics, amorphous 
spheres and needle-like crystal, were found in 
the physical mixture of HP-β-CD and arbutin 
(Plate 1c). As for the inclusion complex, the 
original morphology of both components 
disappeared and some tiny aggregates of 
amorphous pieces with irregular size were 




Plate 1:  Scanning electron micrographs of HP-β-CD (a), arbutin (b), their physical mixture (c), and 
inclusion complex (d) 
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Powder x-ray diffraction patterns of arbutin, HP-
β-CD, their physical mixture and inclusion 
complex are shown in Fig 2. One broad peak 
was observed for the HP-β-CD (Plate 2a), while 
some very sharp crystalline peaks were shown in 
the powder diffraction pattern of arbutin (Fig 2b). 
As shown in Plate 2c, a superimposition of the 
patterns of the two compounds, arbutin and HP-
-CD, was very distinct. However, the powder 
XRD pattern of the inclusion complex was more 
similar to that of the amorphous HP-β-CD and 
did not exhibit the characteristic peaks of arbutin 
(Fig 2d). 
 
TG and DSC curves of arbutin, HP-β-CD and 
inclusion complex are shown in Plate 3. It was 
found that with increase in temperature, HP--
CD began to decompose at about 320 °C and 
then ended at about 420 °C. The decomposing 
peak value (about 360 °C) was obtained from the 
DSC curve (Fig 3a).  The fusion and degradation 
of HP--CD were completed in one step. 
Different from this, the DSC curve of arbutin had 
an obvious endothermic peak where the mass of 
arbutin did not decrease (Fig 3b), suggesting that 
the arbutin melted at about 200 °C. Therefore, 
the degradation of arbutin began at about 
200 °C, and ended at about 370 °C (Plate 3b). 
The TG curve of the inclusion complex was also 
a one step process (Plate 3c), partly proving the 
formation of the complex. The starting 
temperatures for mass loss were about 320°C, 




UV spectroscopy is an important and efficient 
tool for studying the formation of complex of 
arbutin and HP-β-CD. The curves of physical 
mixture and inclusion complex of arbutin and HP-
β-CD did not coincide, which indicates that the 
inclusion complex of arbutin and HP-β-CD was 
not a simple physical mixture. The characteristic 
absorption peaks of their inclusion complex were 
not changed, indicating no new unsaturated 
bond was formed. 
 
Infrared analysis showed that the infrared 
spectrum of the physical mixture of arbutin and 
HP-β-CD was the superimposition of arbutin and 
HP-β-CD. However, the infrared spectrum of the 
inclusion complex of arbutin and HP-β-CD were 
similar to that of arbutin. There were no obvious 
new absorption peaks in the inclusion complex, 
indicating that there was no new chemical bond 
formation during the inclusion complex formation 
process. 
 
Scanning electron microscope captures the 
surface morphology of a sample by the 
interaction between electrons and the sample 
material. The two characteristics, amorphous 
spheres and needle-like crystal, were found in 
the physical mixture of HP-β-CD and arbutin. As 
for the inclusion complex, the original 
morphology of both components disappeared, 
and some tiny aggregates of amorphous pieces 
with irregular size were present, revealing that 
the arbutin did not exist in the crystal state but 
was dispersed in HP-β-CD. 
 
X-ray diffractometry is a very useful method for 
the detection of CDs complexes in powder or 
microcrystalline states. The diffraction pattern of 
the complex is supposed to be clearly distinct 
from that formed from mere superposition of the 
components if a true inclusion complex is 
formed.
 
Plate 2:  X-ray diffraction patterns of HP-β-CD (a), arbutin (b), their physical mixture (c), and inclusion 
complex (d) 
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Figure 3:  TG/DSC curves of HP-β-CD (a), arbutin (b) and their inclusion complex (c) 
 
The diffraction pattern of arbutin which exhibited 
many spikes indicated that it was crystalline, 
while HP-β-CD showed no spikes, indicating that 
it is in amorphous state. The physical mixture of 
arbutin and HP-β-CD could decrease the 
characteristic crystallization peak of arbutin to 
some extent. The inclusion complex showed no 
crystallization peak of arbutin due to the effect of 
HP-β-CD. X-ray diffraction analysis suggested 
that arbutin in the HP-β-CD matrix was 
molecularly dispersed, and existed in an 
amorphous state. 
 
Thermogravimetric (TG) and differential scanning 
calorimetry (DSC) are important methods for 
research on thermal properties of cyclodextrin 
and its inclusion complex. Thermogravimetric -
differential scanning calorimetry combined with 
(DSC-TG) is the latest development in thermal 
analysis technology, which can simultaneously 
test weight changes and heat absorption/heat 
release of samples with increase in temperature.  
The DSC curve of arbtin shows one endothermic 
peak at 320 °C. However, this characteristic 
endothermal peak disappeared in the DSC curve 
of the inclusion complex. This shows that arbutin 
was completely dispersed in HP-β-CD and that 
there was some kind of interaction between 
them, such as hydrogen bonds or van der Waals 
force [24]. The decomposition temperature of the 
complex was about 300 °C, indicating that the 
heat stability of arbutin could be remarkably 





The findings of this study show that the arbutin in 
the inclusion complex is completely dispersed in 
HP-β-CD matrix. It is worth noting that arbutin in 
the HP-β-CD matrix is molecularly dispersed 
without forming a new unsaturated bond. A 
combination of hydrogen bonds or van der Waals 
forces may be responsible for the formation of 
the inclusion complex.  Formation of inclusion 
complex with HP-β-CD can improve the heat 
stability of arbutin remarkably, and enhance its 
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